Pediatric Hematologist/Oncologist (Child Cancer Specialist)
Hello, my name is Jordan Milner, MD, and I am a clinical assistant professor in the division of pediatric hematology oncology at the University of Florida College of Medicine Department of Pediatrics. I became interested in medicine because of the wonderful relationships that are built between physicians and patients and because the field of medicine is always evolving and advancing. I chose pediatric bone marrow transplant (BMT) because I care about patients and helping them face complex underlying diseases.
In medical school, I was a member of the Global Scholar Program at St. George's University School of Medicine for medical students who exhibit academic excellence. I completed my pediatric residency and chief year at Memorial University Medical Center in Savannah, GA, and went on to complete a fellowship in pediatric hematology/oncology at Maria Fareri Children's Hospital at Westchester Medical Center in Valhalla, NY.
I have a strong passion for stem cell transplantation and cellular therapies and have dedicated my research to stem cell graft manipulation and virus specific cytotoxic T-lymphocytes. At the Pediatric Blood & Marrow Transplantation and Cell Therapy Program, we are currently working to bring alpha/beta T cell and B cell depletion for allogeneic stem cell transplants to UF and look forward to opening several trials utilizing this graft manipulation.
I look forward to continuing to serve as an advocate, helping to improve the curative treatment options for sickle cell disease and bring them to the University of Florida.
I am so happy to be a part of a team of innovative experts at the University of Florida. I am a native Floridian and I love to be outside with my family, especially by the water. I enjoy dancing and travelling abroad.
As a pediatric BMT and cellular therapy physician, I often times become a part of the patient鈥檚 family and enjoy advocating for what鈥檚 medically best for them. I look forward to providing outstanding and compassionate care to patients and their families here at BOB体育.
A Phase I trial to determine the safety of targeted immunotherapy with daratumumab (DARA) IV after total body irradiation (TBI)-based myeloablative conditioning and allogeneic hematopoietic cell transplantation (HCT) for children, adolescents, and鈥�
This study will assess the safety, efficacy, and feasibility of 鈲�/尾 CD3+ T-cell and CD19+ B-cell depletion in allogeneic stem cell transplantation in patients with acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), juvenile鈥�
This is a follow-up trial to NYMC 526 (NCT01461837) to assess the safety, efficacy and toxicity of administering Defibrotide prophylaxis for high-risk sickle cell or beta thalassemia patients undergoing a familial haploidentical allogeneic stem cell鈥�
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
See all insurances— Dr. Jordan MilnerAs a pediatric bone marrow transplant physician, Dr. Milner believes in genuine partnership with her patients and their family. Through partnership, they are able to have a strong bond to work through the most difficult challenges in treatment in the most caring way.